-
Stay Connected
Get the latest news on exciting speakers, workshops & learning opportunities at ISDE 2021.
Subscribe for Updates
Esophagectomy remains one of the most demanding operations in gastrointestinal surgery. Patients often enter treatment with weight loss, swallowing difficulty, inflammation, reduced exercise capacity, or the effects of neoadjuvant chemotherapy and radiotherapy. These factors can increase the risk of pulmonary complications, prolonged hospitalization, and delayed recovery.
Prehabilitation aims to improve physiological reserve before surgery. It commonly combines exercise training, nutritional optimization, psychological support, smoking cessation, and careful management of anemia or other medical problems. The approach is increasingly incorporated into enhanced recovery pathways, although the strength of evidence varies across interventions.
The central question is practical: can a structured program produce measurable benefits within the limited time between cancer treatment and esophagectomy? Current research suggests that it can, particularly for functional capacity and nutritional status, but the effect on major complications and long-term survival remains less certain.
Low cardiopulmonary fitness is associated with poorer tolerance of major surgery. Measures such as the six-minute walk distance, cardiopulmonary exercise testing, inspiratory muscle strength, and daily activity levels can help identify patients who may benefit from targeted preparation.
Nutritional risk is equally important. Esophageal cancer can cause inadequate intake for weeks or months, while treatment-related nausea, mucositis, and fatigue may worsen energy and protein deficits. A dietitian-led plan may include oral supplements, texture modification, enteral feeding, or correction of micronutrient deficiencies.
Most published programs use moderate aerobic activity, resistance training, or a combination of both. Walking, cycling, interval exercise, and supervised strength work may be prescribed two to five times weekly, depending on baseline fitness and treatment schedules. Inspiratory muscle training is sometimes added to support respiratory function.
The duration is often short, ranging from two to six weeks. Even a brief program can be useful when it is personalized and monitored. However, adherence is a recurring limitation: fatigue, treatment toxicity, pain, and travel distance may prevent patients from completing the planned regimen.
Studies of preoperative rehabilitation in esophageal cancer generally report improvements in exercise capacity, muscle strength, or nutritional markers. Some randomized and prospective studies also suggest fewer pulmonary complications or a shorter hospital stay. Results are inconsistent because programs differ in intensity, duration, supervision, outcome definitions, and timing.
The evidence is stronger for improving surrogate measures of fitness than for proving a reduction in mortality or recurrence. Many trials are small and single-center, and patients who are able to participate may already be fitter than the wider surgical population. These limitations make it difficult to identify one universally effective protocol.
| Prehabilitation component | Potential benefit | Evidence limitations |
|---|---|---|
| Aerobic exercise | Improved functional capacity and endurance | Variable adherence and program duration |
| Resistance training | Better muscle strength and physical reserve | Limited data on postoperative complications |
| Inspiratory muscle training | May reduce respiratory weakness and pulmonary risk | Protocols and testing methods differ |
| Nutrition support | Improved intake, weight stability, and protein status | Benefit depends on baseline malnutrition and treatment response |
| Psychological support | Better coping, engagement, and treatment participation | Harder to measure with standardized outcomes |
Weight alone does not fully describe surgical risk. A patient can have a normal or high body mass index while experiencing sarcopenia, meaning reduced skeletal muscle quantity or quality. Computed tomography images obtained during cancer staging can sometimes help clinicians assess muscle depletion.
Early dietetic assessment is therefore preferable to waiting for severe weight loss. Protein-rich foods, high-calorie supplements, and appropriate feeding access should be considered alongside symptom control. When oral intake is inadequate, enteral nutrition is generally favored when feasible because it supports gut use and can be integrated into the perioperative plan.
The role of emerging therapies in esophageal inflammation remains an area of research, but such approaches should not be confused with established nutritional or exercise-based prehabilitation.
A successful program must fit the oncology timeline. Surgery may follow neoadjuvant treatment after only a short recovery interval, so referral should occur at diagnosis or before systemic therapy whenever possible. Exercise intensity should be adjusted for anemia, cardiopulmonary disease, bone metastases, neuropathy, and treatment-related complications.
Multidisciplinary coordination is essential. Surgeons, anesthesiologists, oncologists, physiotherapists, dietitians, nurses, and psychologists should share goals and track progress using practical measures. Home-based programs supported by telephone or digital monitoring may improve access, especially for patients who live far from specialist centers.
Useful outcomes include postoperative pulmonary complications, anastomotic leak, readmission, length of stay, time to independent mobility, return to normal diet, and patient-reported quality of life. Functional measures before and after the program can show whether a patient has gained meaningful reserve, even when surgery proceeds as scheduled.
Future research needs larger multicenter trials with standardized exercise prescriptions, nutrition protocols, adherence reporting, and clinically important endpoints. It should also clarify which patients benefit most, how long preparation should last, and whether rehabilitation after surgery produces additive gains.
Prehabilitation should be prescribed rather than treated as generic advice. A baseline assessment can identify frailty, malnutrition, cardiorespiratory limitation, anxiety, and barriers such as transportation or financial strain.
A reasonable clinical framework includes:
The current evidence supports prehabilitation as a feasible component of modern esophageal cancer care, especially for improving functional and nutritional status. Its value is greatest when delivered early, tailored to the patient, and integrated with enhanced recovery rather than offered as a last-minute exercise prescription.
Explore the educational resources and research discussions available through the International Society for Diseases of the Esophagus to follow developments in perioperative care and esophageal health.